Home » Stocks » APM

Aptorum Group Limited (APM)

Stock Price: $2.46 USD -0.07 (-2.77%)
Updated December 3, 4:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 28.47M
Revenue (ttm) 535,166
Net Income (ttm) -18.69M
Shares Out 29.01M
EPS (ttm) -0.54
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day December 3
Last Price $2.46
Previous Close $2.53
Change ($) -0.07
Change (%) -2.77%
Day's Open 2.53
Day's Range 2.46 - 2.56
Day's Volume 199,281
52-Week Range 1.22 - 16.00

More Stats

Market Cap 28.47M
Enterprise Value 28.39M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 29.01M
Float n/a
EPS (basic) -0.64
EPS (diluted) -0.54
FCF / Share -0.49
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 266,777
Short Ratio 0.59
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 53.20
PB Ratio 4.42
Revenue 535,166
Operating Income -18.20M
Net Income -18.69M
Free Cash Flow -14.22M
Net Cash 86,797
Net Cash / Share 0.01
Gross Margin -41.66%
Operating Margin -3,400.52%
Profit Margin -3,491.80%
FCF Margin -2,657.06%
ROA -47.55%
ROE -84.08%
ROIC -81.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(428.46% upside)
Current: $2.46
Target: 13.00
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth39.57%-
Gross Profit-0.260.07
Operating Income-18.20-10.33
Net Income-18.69-14.83
Shares Outstanding29.0127.91
Earnings Per Share-0.64-0.53
Operating Cash Flow-13.38-10.04
Capital Expenditures-0.84-5.65
Free Cash Flow-14.22-15.68
Cash & Equivalents6.5627.24
Total Debt6.4710.30
Net Cash / Debt0.0916.94
Book Value16.3633.11
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Aptorum Group Limited
Employees 36

Stock Information

Ticker Symbol APM
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: APM
IPO Date December 18, 2018


Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers. Its pipeline through the establishment of drug discovery platforms enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The company is also pursuing therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. It also has projects focused on surgical robotics and natural supplement for women undergoing menopause and experiencing related symptoms. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.